| Print
NANOBIOTIX (NANO)
NANOBIOTIXThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Address
Forecast key dates
Name | Key Date |
---|---|
Nanobiotix SA Fourth Quarter Earnings Conference Call for 2025 | 2026-04-03T08:00:00 |
Nanobiotix SA Fourth Quarter Earnings Results for 2025 | 2026-04-02T00:00:00 |
Nanobiotix SA Annual Report for 2025 | 2026-04-02T00:00:00 |
Nanobiotix SA Third Quarter Earnings Results for 2025 | 2025-11-12T00:00:00 |
Nanobiotix SA Third Quarter Earnings Conference Call for 2025 | 2025-11-12T00:00:00 |
Nanobiotix SA Second Quarter Earnings Results for 2025 | 2025-09-18T00:00:00 |
Nanobiotix SA Second Quarter Earnings Conference Call for 2025 | 2025-09-18T00:00:00 |
Nanobiotix SA Annual General Meeting for 2025 | 2025-05-28T14:00:00 |
Nanobiotix SA First Quarter Earnings Conference Call for 2025 | 2025-05-22T08:00:00 |
Nanobiotix SA First Quarter Earnings Results for 2025 | 2025-05-22T00:00:00 |
Full Results Phase 1 Pancreas (ESTRO 2025) | 2025-05-05T08:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.